Duloxetine Hydrochloride is a serotonin-norepinephrine reuptake inhibitor (SNRI) indicated for major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia and chronic musculoskeletal pain. We supply it to US manufacturers of delayed-release capsules.
Data from PubChem (CID 60834) and FDA’s substance registry
CAS number
136434-34-9
Molecular formula
C18H20ClNOS
Molecular weight
333.9g/mol
FDA UNII
IUPAC name
(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine;hydrochloride
InChIKey
BFFSMCNJSOPUAY-LMOVPXPDSA-N
- Appearance
- White to slightly brownish-white solid.
- Solubility
- Slightly soluble in water.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
A secondary amine. N-nitroso-duloxetine led to US capsule recalls in 2024, so ask for confirmatory testing on the API and not only a paper assessment. It also degrades in acid, which is why finished products are enteric-coated.
On the US market
- Reference product
- CymbaltaNDA 021427
- Approved ANDAs
- 16 with a marketed product
- Approved forms and strengths
- Delayed-release capsule (pellets) 20 mg to 120 mg, in 7 strengths
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com
Sertraline Hydrochloride
Selective serotonin reuptake inhibitor (SSRI)
CAS 79559-97-0Escitalopram Oxalate
Selective serotonin reuptake inhibitor (SSRI)
CAS 219861-08-2Bupropion Hydrochloride
Norepinephrine-dopamine reuptake inhibitor
CAS 31677-93-7Trazodone Hydrochloride
Serotonin antagonist and reuptake inhibitor
CAS 25332-39-2